Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 89

1.

Severity of Plasmodium vivax malaria in Karachi: a cross-sectional study.

Mehmood A, Ejaz K, Ahmed T.

J Infect Dev Ctries. 2012 Sep 17;6(9):664-70. doi: 10.3855/jidc.2107.

2.

Plasmodium vivax malaria admissions and risk of mortality in a tertiary-care children's hospital in North India.

Sharma R, Gohain S, Chandra J, Kumar V, Chopra A, Chatterjee S, Aneja S, Dutta AK.

Paediatr Int Child Health. 2012 Aug;32(3):152-7. doi: 10.1179/2046905512Y.0000000012.

PMID:
22824663
3.

Severe disease in children hospitalized with a diagnosis of Plasmodium vivax in south-eastern Pakistan.

Shaikh S, Memon H, Iohano B, Shaikh A, Ahmed I, Baird JK.

Malar J. 2012 May 2;11:144. doi: 10.1186/1475-2875-11-144.

4.

Thrombocytopenia in malaria.

Shaikh QH, Ahmad SM, Abbasi A, Malik SA, Sahito AA, Munir SM.

J Coll Physicians Surg Pak. 2009 Nov;19(11):708-10. doi: 11.2009/JCPSP.708710.

PMID:
19889267
5.

Is vivax malaria really benign? - a Karachi-based study.

Aatif S, Jamal Q, Altaf A, Salimullah.

J Pak Med Assoc. 2013 Jun;63(6):721-4.

6.

SEVERITY OF THROMBOCYTOPENIA IN PATIENTS WITH PLASMODIUM VIVAX MALARIA; A SINGLE CENTER STUDY.

Hafeez M, Lodhi FR, Akhtar Z, Ali MZ, Aijaz A.

J Ayub Med Coll Abbottabad. 2015 Jan-Mar;27(1):61-3.

PMID:
26182739
7.

Complications associated with Plasmodium vivax malaria: a retrospective study from a tertiary care hospital based in Western Uttar Pradesh, India.

Rizvi I, Tripathi DK, Chughtai AM, Beg M, Zaman S, Zaidi N.

Ann Afr Med. 2013 Jul-Sep;12(3):155-9. doi: 10.4103/1596-3519.117624.

8.

Epidemiological features of severe paediatric malaria in north western Ethiopia.

Seboxa T, Snow RW.

East Afr Med J. 1997 Dec;74(12):780-3.

PMID:
9557422
9.

Is benign tertian malaria actually benign?

Gogia A, Kakar A, Byotra SP.

Trop Doct. 2012 Apr;42(2):92-3. doi: 10.1258/td.2011.110295.

PMID:
22431827
10.

Retrospective analysis of vivax malaria patients presenting to tertiary referral centre of Uttarakhand.

Srivastava S, Ahmad S, Shirazi N, Kumar Verma S, Puri P.

Acta Trop. 2011 Feb;117(2):82-5. doi: 10.1016/j.actatropica.2010.10.001. Epub 2010 Oct 11.

PMID:
20943199
11.

How benign is benign tertian malaria?

Sharma A, Khanduri U.

J Vector Borne Dis. 2009 Jun;46(2):141-4.

12.

Severe Plasmodium vivax malaria: a report on serial cases from Bikaner in northwestern India.

Kochar DK, Das A, Kochar SK, Saxena V, Sirohi P, Garg S, Kochar A, Khatri MP, Gupta V.

Am J Trop Med Hyg. 2009 Feb;80(2):194-8.

PMID:
19190212
13.

Plasmodium vivax malaria--is it really benign?

Saini T, Kumhar M, Barjartya HC.

J Indian Med Assoc. 2013 Sep;111(9):609-11.

PMID:
24968525
14.

Clinical features of vivax malaria.

Oh MD, Shin H, Shin D, Kim U, Lee S, Kim N, Choi MH, Chai JY, Choe K.

Am J Trop Med Hyg. 2001 Aug;65(2):143-6.

PMID:
11508390
15.

Comparative features and outcomes of malaria at a tertiary care hospital in Karachi, Pakistan.

Beg MA, Sani N, Mehraj V, Jafri W, Khan MA, Malik A, Menezes E, Hussain R, Smego R Jr.

Int J Infect Dis. 2008 Jan;12(1):37-42. Epub 2007 Jun 18.

16.

Imported malaria in Qatar: a one year hospital-based study in 2005.

Khan FY, Lutof AK, Yassin MA, Khattab MA, Saleh M, Rezeq HY, Almaslamani M.

Travel Med Infect Dis. 2009 Mar;7(2):111-7. doi: 10.1016/j.tmaid.2009.01.003. Epub 2009 Feb 7.

PMID:
19237144
17.

[Acute respiratory distress syndrome (ARDS) as a complication of malaria P.vivax].

Altman A, Gueta I, Grosman T, Schwartz E.

Harefuah. 2010 Sep;149(9):580-2, 620. Hebrew.

PMID:
21302472
18.
19.

Thrombocytopenia in malaria: can platelet counts differentiate malaria from other infections?

Arshad AR.

J Coll Physicians Surg Pak. 2015 Jan;25(1):31-4. doi: 01.2015/JCPSP.3134.

PMID:
25604366
20.

Altered platelet indices as potential markers of severe and complicated malaria caused by Plasmodium vivax: a cross-sectional descriptive study.

Leal-Santos FA, Silva SB, Crepaldi NP, Nery AF, Martin TO, Alves-Junior ER, Fontes CJ.

Malar J. 2013 Dec 27;12:462. doi: 10.1186/1475-2875-12-462.

Supplemental Content

Support Center